Insider trades

Ronald Richard, Director of Emergent BioSolutions EBS, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $263.1K. The latest trade was on 04/30.

Ronald Richard

Director
First filing
23/05/30
Trades
12 trades
Buys / sales
0 / 2
12-month net buying
−$263.1K
Last trade
04/30

Trading activity

Transactions

Trade type
EBS
Open-market sale25/12/0525/12/0921,984 sh2 trades$11.97avg.$263,100.6−18.3%